Results 61 to 70 of about 16,221 (209)
ABSTRACT Objective To evaluate the long‐term impact of a structured, multidisciplinary CS reduction strategy in a high‐complexity Italian hospital. Design Retrospective ecological time‐trend study. Setting Tertiary obstetric care Italian centre. Sample 28 577 deliveries, ≥ 22 weeks' gestation, from 2014 to 2024 were analysed.
Stefania Fieni +4 more
wiley +1 more source
ABSTRACT Introduction Induction of labour is a common intervention. The prostaglandin dinoprostone is often used, but there is increasing evidence that misoprostol may be more effective without compromising safety. This review compares the efficacy and safety of vaginal misoprostol and vaginal dinoprostone.
Georgina Andersson +10 more
wiley +1 more source
Summary Background Equine squamous gastric disease (ESGD) and equine glandular gastric disease (EGGD) can be treated with oral omeprazole, combined with sucralfate or an extended‐release intramuscular omeprazole (ERIO). Objectives To evaluate these different treatments for ESGD and EGGD and assess the influence of inflammatory bowel disease (IBD) on ...
L. C. Kranenburg +6 more
wiley +1 more source
Objective: To determine the frequency of lower-segment caesarean section in patients receiving misoprostol for the induction of labour. Method: The cross-sectional, observational study was conducted at the Kohi Goth Women's Hospital, Karachi, from ...
Adila Abdul Manan +2 more
doaj +1 more source
Background The safest, most effective and fastest combined approaches to induction of labor is unknown. In an open-label randomized clinical trial we evaluated the efficacy of combination of extra-amniotic Foley’s catheter and vaginal misoprostol ...
Alfred Osoti +3 more
doaj +1 more source
ABSTRACT Older patients receiving end‐of‐life palliative care often present with multiple geriatric syndromes, frailty, and comorbid symptom burden, resulting in a high risk of medication‐related harm. This guideline focuses on pharmacological management of distressing symptoms in older patients receiving end‐of‐life or hospice‐oriented palliative care,
Daiping Li +7 more
wiley +1 more source
Misoprostol use in obstetrics [PDF]
Key points • Misoprostol is a prostaglandin E1 (PGE1) analogue that has been on the World Health Organization (WHO) List of Essential Medicines since 2005.
Medeiros, Robinson Dias de +15 more
core
Objetivo: evaluar la eficacia y seguridad del misoprostol frente al metotrexato más misoprostol para el manejo médico de pacientes con aborto retenido o embarazo anembrionado.
Mortimer Arreaza-Graterol +1 more
doaj +3 more sources
ABSTRACT The recent decriminalization of abortion marked a crucial step toward improved reproductive care on the island of Ireland. However, this has not translated into fully accessible abortion provision—barriers, including inaccessible services, persist, leaving gaps that public administration has not formally addressed. In response, informal actors,
Anna Theresa Schmid
wiley +1 more source
Objective: To compare the success rate and side effects of letrozole and misoprostol versus misoprostol alone for medical termination of early pregnancy.
Ho, PC, Lee, VCY, Ng, EHY, Yeung, WSB
core +1 more source

